Silfedrine and Telavancin Hydrochloride

• Generic Name: pseudoephedrine
• Dosage Forms: oral liquid
• Other Brand Names: Chlor Trimeton Nasal Decongestant, Contac Cold, Drixoral Decongestant Non-Drowsy, Elixsure Decongestant, Genaphed, Nasofed, Nexafed, Silfedrine, Sudafed, Sudafed Children's Nasal Decongestant, SudoGest, Suphedrin, Triaminic Softchews Allergy Congestion, Entex, Kid Kare Drops, Seudotabs, Sudafed 12-Hour, Sudafed 24-Hour, Sudodrin, SudoGest 12 Hour, Unifed, Decongestant 12Hour Max St, Shopko Nasal Decongestant, Sudafed 12 Hour, Sudafed 24 Hour, Nasal Decongestant, Psudatabs, Shopko Nasal Decongestant Max, Simply Stuffy, Suphedrine, Zephrex-D

Silfedrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).

Silfedrine is used to treat nasal and sinus congestion, or congestion of the tubes that drain fluid from your inner ears, called the eustachian (yoo-STAY-shun) tubes.

Silfedrine may also be used for purposes not listed in this medication guide.

• Generic Name: telavancin
• Dosage Forms: n.a.
• Other Brand Names: Vibativ

Treatment of nosocomial pneumonia, including hospital-acquired and ventilator-associated pneumonia, caused by susceptible Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA; also known as oxacillin-resistant S. aureus or ORSA]).

If documented or presumed pathogens also include gram-negative or anaerobic bacteria, concomitant use of an anti-infective active against such bacteria may be clinically indicated.

Manufacturer states reserve telavancin for use when alternative treatments for hospital-acquired or ventilator-associated bacterial pneumonia not suitable.

Skin and Skin Structure Infections

Treatment of complicated skin and skin structure infections caused by susceptible S. aureus (including MRSA), Streptococcus pyogenes (group A β-hemolytic streptococci, GAS), S. agalactiae (group B streptococci, GBS), S. anginosus group (includes S. anginosus, S. intermedius, S. constellatus), or Enterococcus faecalis (vancomycin-susceptible strains only).

If documented or presumed pathogens also include gram-negative or anaerobic bacteria, concomitant use of an anti-infective active against such bacteria may be clinically indicated.